Cannabis Use and Suicidal Behaviour in Young Adults Across Washington State and Victoria
medical cannabis research: A longitudinal cohort study linked young adult cannabis use with later suicidal behaviour, while also showing that legalization context alone did not explain regional suicide risk patterns. It keeps the evidence readable for…
Cannabis and Violence Risk: What a Large Meta-analysis Really Shows
medical cannabis research: A 63-study meta-analysis found higher odds of violence perpetration and victimization among cannabis users, but the clinical meaning depends heavily on confounding, dose, psychiatric risk, and study design. It keeps the…
Cannabinoids for Back Pain and Migraine: What Randomized Trials Actually Show
medical cannabis research: A systematic review of five randomized trials found cannabinoid effects depend sharply on condition, product type, route, and THC content, with promising migraine and chronic back pain signals but weak class-wide evidence. It…
Cannabinoids for Low Back Pain and Migraine: What Randomized Trials Actually Show
medical cannabis research: A systematic review of five randomized trials found mixed cannabinoid results: promising signals for vaporized THC plus CBD in acute migraine and VER-01 in chronic low back pain, but no class-wide effect. It keeps the evidence…
Pancreatic Cancer Cannabis Trial Finds Modest THC Dose Signals for Anxiety and Sleep
medical cannabis research: CANPAN pilot data suggest personalized medical cannabis may help selected pancreatic cancer patients, with higher THC exposure linked to anxiety and insomnia improvement, but missing data and small numbers limit certainty. It…
Medical Cannabis Dose and Symptom Control in Pancreatic Cancer
medical cannabis research: CANPAN pilot data suggest low daily THC doses may relate to better anxiety and insomnia scores in pancreatic cancer, but missing data and small sample size require careful interpretation. It keeps the evidence readable for…
Medical Cannabis Dose Patterns and Symptom Control in Pancreatic Cancer
medical cannabis research: CANPAN pilot data suggest modest THC dosing may relate to anxiety, insomnia, and multi-symptom improvement in pancreatic cancer, while also exposing major feasibility challenges in advanced cancer research. It keeps the…
What CANPAN Suggests About THC Dose and Symptoms in Pancreatic Cancer
medical cannabis research: A small CANPAN analysis links higher daily THC exposure with better anxiety and insomnia scores in pancreatic cancer, while also exposing major feasibility and missing-data challenges for future trials. It keeps the evidence…
Intranasal lipid carrier cannabidiol for Dravet and Lennox-Gastaut syndromes remains promising but unproven
medical cannabis research: A new review argues that intranasal nanostructured lipid carrier CBD could improve brain delivery for severe pediatric epilepsies, but the evidence remains preclinical and not yet patient-ready. It keeps the evidence readable…
Nose to Brain CBD Nanocarriers for Dravet and Lennox Gastaut Syndromes
medical cannabis research: A new review argues that intranasal nanostructured lipid CBD could improve brain delivery for severe childhood epilepsies, but the concept remains preclinical and unproven in children. It keeps the evidence readable for…
